Middle East & Africa Digital Thoracic Drainage Devices Market Forecast to 2030 - Regional Analysis - by Product Type, Application, and End User

Executive Summary

At 3.7% CAGR, the Middle East & Africa Digital Thoracic Drainage Devices Market is speculated to be worth US$ 6.23 million by 2030.

According to this research, the Middle East & Africa digital thoracic drainage devices market was valued at US$ 4.65 million in 2022 and is expected to reach US$ 6.23 million by 2030, registering a CAGR of 3.7% from 2022 to 2030. Need for digital thoracic drainage post-thoracic surgery and advantages of digital thoracic drainage devices over analog thoracic drainage devices are among the critical factors attributed to the Middle East & Africa digital thoracic drainage devices market expansion.

The count of thoracic surgeries performed is increasing due to the rising incidence of lung cancer. ~80% of the total thoracic surgeries are performed for the treatment of lung cancer and its types. The type of lung cancer includes oesophageal cancer and the cancers diagnosed in the pericardium, the chest wall, and mediastinum tumors. According to the World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. The number of thoracic surgeries performed worldwide has increased notably with the prevalence of the disease and a surge in its diagnosis. The number of thoracic surgeries would continue to increase in the coming years with the rising incidence of lung cancer. Thus, the demand for digital thoracic drainage devices is increasing with the rising incidence of lung cancer. The field of thoracic surgery is growing technically and technologically into a prominent surgical specialty. Thoracic surgery has witnessed progress due to the developments made in the minimally invasive approaches. In addition, the developments have been made for peri-operative care also it has integrated surgery into treatment of chest diseases through multi-modality treatment.

Further procedures, such as elective segmentectomy, enhanced recovery programs, uniport surgery, and adjuvant target therapy has allowed treatments for early-stage lung cancer, resulting in increasing number of thoracic surgeries. Moreover, the number of thoracic surgeries is increasing with technical developments, leading to much better results than surgeries performed a decade ago. Most thoracic surgeries are performed robotically or by video-assisted thoracoscopic surgery (VATS) lobectomy, which results in fewer complications and faster recovery. Thoracic drainage devices are essential post-surgery to remove large air leakage and excessive fluid from the pleural cavity. Apart from lung cancers, thoracic surgeries are performed for treating cardiovascular diseases and other chronic diseases. These procedures also include first rib resection for thoracic outlet syndrome, myotomy for Achalasia, esophagectomy and reconstruction for end-stage benign oesophageal disease, thymectomy for Myasthenia Gravis, sympathectomy for hyperhidrosis, and so on. These diseases are common among elderlies, and people suffering from respiratory disorders and other health conditions. Thus, a rise in the geriatric population triggers the number of thoracic surgeries performed as a treatment, thereby leading to the need for digital thoracic drainage devices.

On the contrary, lack of skilled personnel hampers the Middle East & Africa digital thoracic drainage devices market.

Based on product type, the Middle East & Africa digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held 84.0% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 3.90 million. It is projected to garner US$ 5.16 million by 2030 to expand at 3.5% CAGR during 2022-2030.

Based on application, the Middle East & Africa digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held 45.8% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 2.13 million. It is projected to garner US$ 2.95 million by 2030 to expand at 4.2% CAGR during 2022-2030.

Based on end user, the Middle East & Africa digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 48.9% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 2.27 million. It is projected to garner US$ 3.15 million by 2030 to expand at 4.1% CAGR during 2022-2030.

Based on country, the Middle East & Africa digital thoracic drainage devices market has been categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 27.7% share of Middle East & Africa digital thoracic drainage devices market in 2022. It was assessed at US$ 1.29 million in 2022 and is likely to hit US$ 1.60 million by 2030, exhibiting a CAGR of 2.8% during 2022-2030.

Key players operating in the Middle East & Africa digital thoracic drainage devices market are Cardinal Health Inc, Getinge AB, Medela AG, Redax SpA, and Teleflex Inc, among others.

• Cardinal Health Inc
• Getinge AB
• Medela AG
• Redax SpA
• Teleflex Inc